Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basimglurant in Fragile X Syndrome
NCT01517698Phase 2Completed
- Sponsor
- Roche
- Start
- May 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of basimglurant in Fragile X syndrome (FXS), sponsored by Roche. Started May 2012; status: completed.
02
Drugs
basimglurant
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT01517698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01517698.